OptiBiotix Health Plc (AIM:OPTI)
London
· Delayed Price · Currency is GBP · Price in GBX 6.00
+0.25 (4.35%)
Mar 9, 2026, 1:05 PM GMT
OptiBiotix Health Revenue
OptiBiotix Health had revenue of 557.00K GBP in the half year ending June 30, 2025, with 58.69% growth. This brings the company's revenue in the last twelve months to 1.15M, up 102.28% year-over-year. In the year 2024, OptiBiotix Health had annual revenue of 870.00K with 35.09% growth.
Revenue (ttm)
1.15M
Revenue Growth
+102.28%
P/S Ratio
5.16
Revenue / Employee
115.10K
Employees
10
Market Cap
5.94M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 870.00K | 226.00K | 35.09% |
| Dec 31, 2023 | 644.00K | 187.00K | 40.92% |
| Dec 31, 2022 | 457.00K | -1.76M | -79.35% |
| Dec 31, 2021 | 2.21M | 689.75K | 45.28% |
| Dec 31, 2020 | 1.52M | 835.66K | 121.54% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Nov 30, 2018 | Pro | Pro | Pro |
| Nov 30, 2017 | Pro | Pro | Pro |
| Nov 30, 2016 | Pro | Pro | Pro |
| Nov 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CRISM Therapeutics | 25.00K |
| IXICO | 6.53M |
| Futura Medical | 7.93M |
| Oxford BioDynamics | 1.10M |
| ValiRx | 49.78K |
| Fusion Antibodies | 1.60M |